智通财经APP讯,福元医药(601089.SH)发布公告,公司收到国家药品监督管理局核准签发的葡甲胺原料药《化学原料药上市申请批准通知书》,葡甲胺用于静脉和逆行性尿路造影;脑、胸、腹及四肢血管造影,静脉造影及CT。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.